HCV: The Journey from Discovery to a Cure
Springer International Publishing
Chapter title |
Discovery of Voxilaprevir (GS-9857): The Pan-Genotypic Hepatitis C Virus NS3/4A Protease Inhibitor Utilized as a Component of Vosevi ®
|
---|---|
Chapter number | 61 |
Book title |
HCV: The Journey from Discovery to a Cure
|
Published by |
Springer, Cham, January 2019
|
DOI | 10.1007/7355_2018_61 |
Book ISBNs |
978-3-03-028206-6, 978-3-03-028207-3
|
Authors |
James G. Taylor |
Country | Count | As % |
---|---|---|
Unknown | 6 | 100% |
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 1 | 17% |
Student > Bachelor | 1 | 17% |
Researcher | 1 | 17% |
Student > Postgraduate | 1 | 17% |
Student > Master | 1 | 17% |
Other | 0 | 0% |
Unknown | 1 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Chemistry | 2 | 33% |
Medicine and Dentistry | 2 | 33% |
Unknown | 2 | 33% |